Synapse · 2014 · 22 citations · 147 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceMolecular PharmacologyNeuropharmacologyDendritic Spine PlasticityNeuroprotectionNeuroprotective PharmacologyNeuropsychiatric PharmacotherapyPsychostimulant PharmacologyKetamine PharmacologyKetamine TreatmentNmda Receptor AntagonismNmda Receptor AntagonistsNmda Receptor PharmacologyNmda Receptor SignalingNmda ReceptorsSpine Density Regulation
The authors demonstrate that different NMDAR antagonists (ketamine and MK-801) have varying effects on spine density depending on dose, drug regimen, and brain region. While acute ketamine treatment increases cortical spine density in mice, subchronic exposure to either drug reduces spine density in both the cortex and striatum.
147
Depression: a new animal model sensitive to antidepressant treatments
Roger D. Porsolt, Manuel Pichon, M Jalfre · Nature · 1977 · 4.4K citations
Medicine, Neuroscience, Psychiatry +12
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
Luca Santarelli, Michael Saxe, Cornelius T. Gross et al. · Science · 2003 · 4.3K citations · Full text
Medicine, Neurobiology, Neuroscience +16
Antidepressant effects of ketamine in depressed patients
Robert Berman, Angela Cappiello, Amit Anand et al. · Biological Psychiatry · 2000 · 3.8K citations
Medicine, Pharmacology, Psychiatry +14
The tail suspension test: A new method for screening antidepressants in mice
Lucien Stéru, R Chermat, Bernard Thierry et al. · Psychopharmacology · 1985 · 3.5K citations